AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 9466503 — Biomarker: AR mRNA
Type: Predictive Biomarker (PRD)
Genes: AR; DHTR; NR3C4
Study 30954304 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 25611207 — Biomarker: IL-6 and IL-10
Type: Safety Biomarker (SAF)
Study 22886783 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 22886783 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 19440073 — Biomarker: Serum testosterone
Type: Surrogate Endpoint (SUR)
Study 15823769 — Biomarker: Serum luteinizing hormone
Type: Surrogate Endpoint (SUR)
Study 7930025 — Biomarker: Pulmonary vascular resistance
Type: Surrogate Endpoint (SUR)
Study 26008690 — Biomarker: Valproic acid
Type: Pharmacodynamic Biomarker (PDY)
Study 11411653 — Biomarker: Arginine vasopressin
Type: Predictive Biomarker (PRD)
Genes: AVP; ARVP; VP
Study 11411653 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 9121968 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 25389256 — Biomarker: High density lipoprotein cholesterol
Type: Pharmacodynamic Biomarker (PDY)
Study 18385420 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 16939743 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 31394921 — Biomarker: LAT mRNA
Type: Predictive Biomarker (PRD)
Genes: LAT
Study 16136469 — Biomarker: Interferon gamma
Type: Safety Biomarker (SAF); Monitoring Biomarker (MOI)
Genes: IFNG
Study 15207760 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 16995864 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 25548079 — Biomarker: Hyaluronic acid
Type: Safety Biomarker (SAF)
Study 6908909 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 28506339 — Biomarker: AR mRNA
Type: Predictive Biomarker (PRD)
Genes: AR; DHTR; NR3C4
Study 25391252 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 17761367 — Biomarker: GPI mRNA
Type: Predictive Biomarker (PRD)
Genes: GPI
Study 15489632 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 31115844 — Biomarker: Erbb2 tyrosine kinase receptor
Type: Predictive Biomarker (PRD)
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 31115844 — Biomarker: PI3 mRNA
Type: Predictive Biomarker (PRD)
Genes: PI3; WAP3; WFDC14
Study 29161288 — Biomarker: CCR5 mRNA
Type: Predictive Biomarker (PRD)
Genes: CCR5; CMKBR5
Study 29161288 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 24123845 — Biomarker: Serum testosterone
Type: Surrogate Endpoint (SUR)
Study 17881423 — Biomarker: Angiotensin-converting enzyme
Type: Pharmacodynamic Biomarker (PDY)
Genes: ACE; DCP; DCP1
Study 1579228 — Biomarker: TRH mRNA
Type: Predictive Biomarker (PRD)
Genes: TRH
Study 27160380 — Biomarker: Complement C3
Type: Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: C3; CPAMD1
Study 16237621 — Biomarker: HR mRNA
Type: Predictive Biomarker (PRD)
Genes: HR
Study 30526600 — Biomarker: DDIT3 mRNA
Type: Predictive Biomarker (PRD)
Genes: DDIT3; CHOP; CHOP10; GADD153
Study 2503018 — Biomarker: Cyclic guanosine monophosphate
Type: Pharmacodynamic Biomarker (PDY)
Study 21245130 — Biomarker: Intact parathyroid hormone
Type: Predictive Biomarker (PRD)
Study 21245130 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 19817198 — Biomarker: SPR mRNA
Type: Predictive Biomarker (PRD)
Genes: SPR
Study 18184041 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 18184041 — Biomarker: Interleukin 6
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: IL6; IFNB2
Study 9355902 — Biomarker: Tyrosine-protein kinase ABL1
Type: Pharmacodynamic Biomarker (PDY)
Genes: ABL1; ABL; JTK7
Study 3513518 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 23711288 — Biomarker: BPI mRNA
Type: Predictive Biomarker (PRD)
Genes: BPI
Study 10372738 — Biomarker: POMC
Type: Predictive Biomarker (PRD)
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 10372738 — Biomarker: CRH mRNA
Type: Predictive Biomarker (PRD)
Genes: CRH
Study 24670970 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 24670970 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 17622238 — Biomarker: HR mRNA
Type: Predictive Biomarker (PRD)
Genes: HR
Study 17622238 — Biomarker: Hormone receptor
Type: Predictive Biomarker (PRD)
Study 15826438 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 25584994 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 11301186 — Biomarker: KLRD1 mRNA
Type: Predictive Biomarker (PRD)
Genes: KLRD1; CD94
Study 11301186 — Biomarker: Interferon gamma
Type: Safety Biomarker (SAF); Monitoring Biomarker (MOI)
Genes: IFNG
Study 11301186 — Biomarker: Interleukin 2
Type: Safety Biomarker (SAF)
Genes: IL2
Study 11301186 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 11301186 — Biomarker: IL2
Type: Predictive Biomarker (PRD)
Genes: IL-2; TCGF
Study 11301186 — Biomarker: Interleukin 13
Type: Predictive Biomarker (PRD); Monitoring Biomarker (MOI)
Genes: IL13; NC30
Study 3882141 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 22500388 — Biomarker: TG mRNA
Type: Predictive Biomarker (PRD)
Genes: TG
Study 22500388 — Biomarker: Serum creatinine
Type: Surrogate Endpoint (SUR)
Study 30223083 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 28838475 — Biomarker: CD34 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD34
Study 28838475 — Biomarker: Vascular endothelial growth factor receptor 2
Type: Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY)
Genes: KDR; FLK1; VEGFR2
Study 28838475 — Biomarker: KIT
Type: Predictive Biomarker (PRD)
Genes: CD117; SCFR; C-Kit
Study 28838475 — Biomarker: Interleukin 6
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: IL6; IFNB2
Study 28838475 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 28838475 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 25377657 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 15016023 — Biomarker: Probing pocket depth
Type: Surrogate Endpoint (SUR)
Study 3283620 — Biomarker: DNM1 mRNA
Type: Predictive Biomarker (PRD)
Genes: DNM1; DNM
Study 29413364 — Biomarker: Interleukin 1
Type: Safety Biomarker (SAF)
Study 28662808 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 12888055 — Biomarker: AMD1 mRNA
Type: Predictive Biomarker (PRD)
Genes: AMD1; AMD
Study 31905382 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 21131387 — Biomarker: B-type natriuretic peptide
Type: Safety Biomarker (SAF)
Genes: NPPB
Study 19546825 — Biomarker: Estrogen receptor
Type: Predictive Biomarker (PRD)
Genes: ESR1; ESR; NR3A1
Study 19546825 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 8318063 — Biomarker: TG mRNA
Type: Predictive Biomarker (PRD)
Genes: TG
Study 8318063 — Biomarker: LPL mRNA
Type: Predictive Biomarker (PRD)
Genes: LPL; LIPD
Study 8318063 — Biomarker: HES1 mRNA
Type: Predictive Biomarker (PRD)
Genes: HES1; BHLHB39; HL; HRY
Study 20127900 — Biomarker: Serum creatinine
Type: Surrogate Endpoint (SUR)
Study 15232793 — Biomarker: Serum phosphate
Type: Pharmacodynamic Biomarker (PDY)
Study 15232793 — Biomarker: Serum calcium
Type: Surrogate Endpoint (SUR)
Study 11716652 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 29540293 — Biomarker: CGA mRNA
Type: Predictive Biomarker (PRD)
Genes: CGA
Study 18545070 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 15714981 — Biomarker: NPEPPS mRNA
Type: Predictive Biomarker (PRD)
Genes: NPEPPS; PSA
Study 11760378 — Biomarker: Cyclic guanosine monophosphate
Type: Pharmacodynamic Biomarker (PDY)
Study 11760378 — Biomarker: Serum methemoglobin
Type: Surrogate Endpoint (SUR)
Study 23806212 — Biomarker: HSPA5 mRNA
Type: Predictive Biomarker (PRD)
Genes: HSPA5; GRP78
Study 23806212 — Biomarker: HSP90B1 mRNA
Type: Predictive Biomarker (PRD)
Genes: HSP90B1; GRP94; TRA1
Study 23806212 — Biomarker: Cytochrome c
Type: Safety Biomarker (SAF)
Study 11881701 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 17086764 — Biomarker: HR mRNA
Type: Predictive Biomarker (PRD)
Genes: HR
Study 17086764 — Biomarker: SELENBP1 mRNA
Type: Predictive Biomarker (PRD)
Genes: SELENBP1; SBP
Study 17086764 — Biomarker: TPR mRNA
Type: Predictive Biomarker (PRD)
Genes: TPR
Study 15536018 — Biomarker: Angiotensin-converting enzyme
Type: Pharmacodynamic Biomarker (PDY)
Genes: ACE; DCP; DCP1
Study 9390698 — Biomarker: Nerve growth factor
Type: Predictive Biomarker (PRD)
Genes: NGF; NGFB
Study 23484524 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 23484524 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 23484524 — Biomarker: High density lipoprotein cholesterol
Type: Pharmacodynamic Biomarker (PDY)
Study 20141706 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 27373 — Biomarker: Blood coagulation
Type: Pharmacodynamic Biomarker (PDY)
Study 31879752 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 19619331 — Biomarker: IPO13 mRNA
Type: Predictive Biomarker (PRD)
Genes: IPO13; KIAA0724; RANBP13
Study 15232663 — Biomarker: CYP3A4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CYP3A4; CYP3A3
Study 9660383 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 8704425 — Biomarker: Antithrombin-III
Type: Safety Biomarker (SAF)
Genes: SERPINC1; AT3; PRO0309
Study 8704425 — Biomarker: PC mRNA
Type: Predictive Biomarker (PRD)
Genes: PC
Study 27039945 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 27039945 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 12534314 — Biomarker: Valproic acid
Type: Pharmacodynamic Biomarker (PDY)
Study 10921541 — Biomarker: MB mRNA
Type: Predictive Biomarker (PRD)
Genes: MB
Study 10921541 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 20223500 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 16756149 — Biomarker: Superoxide dismutase Cu-Zn
Type: Pharmacodynamic Biomarker (PDY)
Genes: SOD1
Study 23767865 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 11189683 — Biomarker: Ovarian carcinoma antigen CA125
Type: Monitoring Biomarker (MOI)
Genes: MUC16; CA125
Study 3303916 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 27744141 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 27744141 — Biomarker: B-type natriuretic peptide
Type: Safety Biomarker (SAF)
Genes: NPPB
Study 18072367 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 12074357 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 10583039 — Biomarker: CYP1A2 mRNA
Type: Predictive Biomarker (PRD)
Genes: CYP1A2
Study 25163948 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 7821128 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 22382047 — Biomarker: High density lipoprotein cholesterol
Type: Pharmacodynamic Biomarker (PDY)
Study 22382047 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 15681602 — Biomarker: NPEPPS mRNA
Type: Predictive Biomarker (PRD)
Genes: NPEPPS; PSA
Study 10641740 — Biomarker: Eosinophil cationic protein
Type: Safety Biomarker (SAF)
Genes: RNASE3; ECP; RNS3
Study 10641740 — Biomarker: Interleukin 8
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Genes: CXCL8; IL8
Study 1097489 — Biomarker: Serum uric acid
Type: Surrogate Endpoint (SUR)
Study 25819139 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 24618266 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 31758571 — Biomarker: SAT1 mRNA
Type: Predictive Biomarker (PRD)
Genes: SAT1; SAT
Study 29665833 — Biomarker: Angiotensin-converting enzyme
Type: Pharmacodynamic Biomarker (PDY)
Genes: ACE; DCP; DCP1
Study 29665833 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 23032305 — Biomarker: DRD2 mRNA
Type: Predictive Biomarker (PRD)
Genes: DRD2
Study 23032305 — Biomarker: DRD2
Type: Safety Biomarker (SAF)
Study 11099170 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 4047384 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 26989892 — Biomarker: Serum uric acid
Type: Surrogate Endpoint (SUR)
Study 26989892 — Biomarker: Serum creatinine
Type: Surrogate Endpoint (SUR)
Study 16007562 — Biomarker: Serum albumin
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY)
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 7832339 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 26372 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 23911139 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 18671798 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 11457745 — Biomarker: Angiotensin-converting enzyme
Type: Pharmacodynamic Biomarker (PDY)
Genes: ACE; DCP; DCP1
Study 25243955 — Biomarker: HBV DNA
Type: Monitoring Biomarker (MOI)
Study 20388472 — Biomarker: Interleukin 8
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Genes: CXCL8; IL8
Study 18042503 — Biomarker: CD4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD4
Study 9012303 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 19625064 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 19625064 — Biomarker: Interleukin 6
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: IL6; IFNB2
Study 19625064 — Biomarker: Free fatty acids
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY)
Study 28916534 — Biomarker: Valproic acid
Type: Pharmacodynamic Biomarker (PDY)
Study 20650654 — Biomarker: Serum phosphate
Type: Pharmacodynamic Biomarker (PDY)
Study 20650654 — Biomarker: Serum albumin
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY)
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 16911911 — Biomarker: Angiotensin-converting enzyme
Type: Pharmacodynamic Biomarker (PDY)
Genes: ACE; DCP; DCP1
Study 11282761 — Biomarker: Pulmonary vascular resistance
Type: Surrogate Endpoint (SUR)
Study 22948945 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 22948945 — Biomarker: High density lipoprotein cholesterol
Type: Pharmacodynamic Biomarker (PDY)
Study 12903909 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 10769855 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 9069567 — Biomarker: High density lipoprotein cholesterol
Type: Pharmacodynamic Biomarker (PDY)
Study 27378824 — Biomarker: Matrix metalloproteinase 9
Type: Pharmacodynamic Biomarker (PDY)
Genes: MMP9; CLG4B
Study 22055594 — Biomarker: HP mRNA
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Genes: HP
Study 18434749 — Biomarker: Serum calcium
Type: Surrogate Endpoint (SUR)
Study 18434749 — Biomarker: Intact parathyroid hormone
Type: Predictive Biomarker (PRD)
Study 18434749 — Biomarker: Serum intact parathyroid hormone
Type: Surrogate Endpoint (SUR)
Study 18434749 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 18434749 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 17173490 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 12706405 — Biomarker: CD4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD4
Study 12706405 — Biomarker: Interleukin 2
Type: Safety Biomarker (SAF)
Genes: IL2
Study 11070565 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 24708832 — Biomarker: High density lipoprotein cholesterol
Type: Pharmacodynamic Biomarker (PDY)
Study 24708832 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 16055524 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 12114885 — Biomarker: MTHFR
Type: Safety Biomarker (SAF)
Study 26295638 — Biomarker: IK mRNA
Type: Predictive Biomarker (PRD)
Genes: IK; RED; RER
Study 17785486 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 12297207 — Biomarker: High density lipoprotein cholesterol
Type: Pharmacodynamic Biomarker (PDY)
Study 12297207 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 12297207 — Biomarker: Vitamin B12
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI)
Study 10995137 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 23289009 — Biomarker: CD4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD4
Study 23289009 — Biomarker: B-lymphocyte surface antigen B4
Type: Predictive Biomarker (PRD)
Genes: CD19
Study 21258242 — Biomarker: Adrenomedullin
Type: Safety Biomarker (SAF); Monitoring Biomarker (MOI)
Genes: ADM; AM
Study 31329991 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 22486134 — Biomarker: Serum albumin
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY)
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 21138627 — Biomarker: HBV DNA
Type: Monitoring Biomarker (MOI)
Study 18702961 — Biomarker: Serum creatinine
Type: Surrogate Endpoint (SUR)
Study 12859561 — Biomarker: Myeloperoxidase
Type: Safety Biomarker (SAF)
Genes: MPO
Study 12859561 — Biomarker: Interleukin 8
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Genes: CXCL8; IL8
Study 10473963 — Biomarker: RALA mRNA
Type: Predictive Biomarker (PRD)
Genes: RALA; RAL
Study 1932377 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 1932377 — Biomarker: Interleukin 1
Type: Safety Biomarker (SAF)
Study 1932377 — Biomarker: Plasminogen activator inhibitor
Type: Safety Biomarker (SAF)
Genes: SERPINE1; PAI1; PLANH1
Study 29895522 — Biomarker: FGR mRNA
Type: Predictive Biomarker (PRD)
Genes: FGR; SRC2
Study 29895522 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 16191750 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 21593577 — Biomarker: FEV mRNA
Type: Predictive Biomarker (PRD)
Genes: FEV; PET1
Study 24332254 — Biomarker: CCL20 mRNA
Type: Predictive Biomarker (PRD)
Genes: CCL20; LARC; MIP3A; SCYA20
Study 11851576 — Biomarker: Estrogen receptor
Type: Predictive Biomarker (PRD)
Genes: ESR1; ESR; NR3A1
Study 10209802 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 9159420 — Biomarker: Serum luteinizing hormone
Type: Surrogate Endpoint (SUR)
Study 8187240 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 31051259 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 26634642 — Biomarker: B-lymphocyte surface antigen B4
Type: Predictive Biomarker (PRD)
Genes: CD19
Study 26634642 — Biomarker: CD27 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD27; TNFRSF7
Study 18838564 — Biomarker: Angiotensin-converting enzyme
Type: Pharmacodynamic Biomarker (PDY)
Genes: ACE; DCP; DCP1
Study 9401251 — Biomarker: CD4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD4
Study 9401251 — Biomarker: FCGR3B
Type: Predictive Biomarker (PRD)
Genes: CD16; CD16b; FcgammaRIIIb; FcRIIIb
Study 9401251 — Biomarker: Leukocyte surface antigen Leu-16
Type: Predictive Biomarker (PRD)
Genes: MS4A1; CD20
Study 16810105 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 16810105 — Biomarker: Interleukin 6
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: IL6; IFNB2
Study 16810105 — Biomarker: Interleukin 8
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Genes: CXCL8; IL8
Study 11061539 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 11061539 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 8299405 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 8299405 — Biomarker: High density lipoprotein cholesterol
Type: Pharmacodynamic Biomarker (PDY)
Study 29405231 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 16009103 — Biomarker: Serum creatinine
Type: Surrogate Endpoint (SUR)
Study 16009103 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 26154086 — Biomarker: TG mRNA
Type: Predictive Biomarker (PRD)
Genes: TG
Study 26154086 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 8865702 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 8865702 — Biomarker: Pulmonary vascular resistance
Type: Surrogate Endpoint (SUR)
Study 1371291 — Biomarker: Serum testosterone
Type: Surrogate Endpoint (SUR)
Study 27339398 — Biomarker: MSC mRNA
Type: Predictive Biomarker (PRD)
Genes: MSC; ABF1; BHLHA22
Study 24624390 — Biomarker: Probing pocket depth
Type: Surrogate Endpoint (SUR)
Study 15165934 — Biomarker: Plasminogen activator inhibitor
Type: Safety Biomarker (SAF)
Genes: SERPINE1; PAI1; PLANH1
Study 15165934 — Biomarker: C-C motif chemokine 2
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CCL2; MCP1; SCYA2
Study 2433081 — Biomarker: Arginine vasopressin
Type: Predictive Biomarker (PRD)
Genes: AVP; ARVP; VP
Study 2433081 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 27334415 — Biomarker: Multidrug resistance protein 1
Type: Predictive Biomarker (PRD)
Genes: ABCB1; MDR1; PGY1
Study 27334415 — Biomarker: CYP3A5 mRNA
Type: Predictive Biomarker (PRD)
Genes: CYP3A5
Study 27334415 — Biomarker: CYP3A4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CYP3A4; CYP3A3
Study 27334415 — Biomarker: NR1I2 mRNA
Type: Predictive Biomarker (PRD)
Genes: NR1I2; PXR
Study 27334415 — Biomarker: PPP3CA mRNA
Type: Predictive Biomarker (PRD)
Genes: PPP3CA; CALNA; CNA
Study 27334415 — Biomarker: PPP3CB mRNA
Type: Predictive Biomarker (PRD)
Genes: PPP3CB; CALNA2; CALNB; CNA2